News

Article

Long-term blood pressure variability and visual field progression in glaucoma

Author(s):

Key Takeaways

  • Higher mean BP and BP variability are linked to faster VF deterioration in glaucoma patients.
  • The study analyzed 1,674 eyes from 985 patients, with an average follow-up of eight years.
SHOW MORE

This retrospective cohort study was designed to provide further information on the association between BP parameters and VF progression over time.

(Image Credit: AdobeStock/interstid)

(Image Credit: AdobeStock/interstid)

A newly published study1 reported that higher mean blood pressure (BP) levels and higher standard deviation (SD) of BP are associated with faster progression of visual field (VF) defects in patients with glaucoma.

Vincent Q. Pham, BS, and colleagues from the Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, University of California, San Diego, La Jolla, CA, reported their results in JAMA Ophthalmology.

They pointed out that the association between blood pressure (BP) and glaucoma progression has been studied previously.2,3 Impaired autoregulation of the vasculature, especially in the optic nerve head, was proposed as a key risk factor for glaucomatous progression.4 However, it remains uncertain whether these vascular changes are a cause or a consequence of glaucoma, they commented.

Blood pressure study and findings

This was a retrospective cohort study designed to provide further information on the association between BP parameters and VF progression over time. The study included patients with suspected or confirmed glaucoma who had been part of the Diagnostic Innovations in Glaucoma Study and the African Descent and Glaucoma Evaluation Study. BP and VF testing was performed from November 2000 to December 2022.

The main outcome measures were the mean and SD values of the systolic and diastolic arterial pressures, which were incorporated into multivariable mixed-effect models to look at association between BP parameters and mean intraocular pressure (IOP) with rates of VF mean deviation loss. The BP parameters, including the mean arterial pressure (MAP), systolic arterial pressure (SAP), and diastolic arterial pressure (DAP) were analyzed, according to the authors, in 3 separate models each incorporating their mean values and SDs. Two-way interaction terms and 3-way interaction terms for each combination of the mean BP, SD of the BP, and the mean IOP were included in the multivariable analysis.

The cohort included 1,674 eyes of 985 patients (mean age, 61.2 years).

The investigators reported that the mean change in the VF mean deviation was −0.13 (95% confidence interval [CI], −0.16 to −0.10) decibels (dB) annually over a mean follow-up of 8.0 years.

The interaction terms of higher mean BP and higher SD of the BP were associated with faster annual mean deviation changes for the MAP (0.02; 95% CI, 0.01-0.04 dB annually per 1-mm Hg higher; P = 0.001) and DAP (0.02; 95% CI, 0.01-0.03 dB annually per 1-mm Hg higher; P < 0.001). The interaction term of the higher SD of the BP and higher mean IOP was associated with faster annual mean deviation changes for the MAP (0.01; 95% CI, 0.00-0.02 μm per 1-mm Hg higher; P = 0.003) and DAP (0.01; 95% CI, 0.00-0.01 μm per 1-mm Hg higher; P = 0.001).

The authors concluded, “In this cohort study, the higher mean BP and higher SD of blood pressure were associated with faster VF progression. These findings suggest that long-term variability of the BP may be a modifier of the association between the IOP and VF progression in glaucoma.”

References:
  1. Pham VQ, Nishida T, Moghimi S, et al.Long-term blood pressure variability and visual field progression in glaucoma. JAMA Ophthalmol. Published online November 14, 2024. doi:10.1001/jamaophthalmol.2024.4868
  2. Mohammadzadeh V, Su E, Mohammadi M, et al. Association of blood pressure with rates of macular ganglion cell complex thinning in patients with glaucoma. JAMA Ophthalmol. 2023;141:251-257. doi:10.1001/jamaophthalmol.2022.6092
  3. Jammal AA, Berchuck SI, Mariottoni EB, et al. Blood pressure and glaucomatous progression in a large clinical population. Ophthalmology. 2022;129:161-170. doi:10.1016/j.ophtha.2021.08.021
  4. Leung DYL, Tham CC. Normal-tension glaucoma: current concepts and approaches-A review. Clin Exp Ophthalmol. 2022;50:247-259. doi:10.1111/ceo.14043
Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Deb Ristvedt, DO's CIME 2024 Talk Highlights Innovations in Treating Glaucoma via the Trabecular Meshwork
© 2024 MJH Life Sciences

All rights reserved.